- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: September 2014
One of the questions I had before the trip was – can Watson computer be a challenge for a physician? Now after a day at the IBM I do have some thoughts on that topic. We were presented with a … Continue reading
Since 3 weeks I take part in the scholarship SIMS program. After one week of lectures at the IBM Warsaw, we went to Fraunhofer Institutes in Leipzig and Dresden, Max Planck institute in Dresden. In Fraunhofer IZI in Dresden I … Continue reading